elocon kreem
organon n.v. - mometasoon - kreem - 1mg 1g 30g 1tk; 1mg 1g 50g 1tk; 1mg 1g 20g 1tk
elocon nahalahus
organon n.v. - mometasoon - nahalahus - 1mg 1g 20ml 1tk; 1mg 1g 50ml 1tk
elocon salv
organon n.v. - mometasoon - salv - 1mg 1g 20g 1tk; 1mg 1g 50g 1tk
kyntheum
leo pharma a/s - brodalumab - psoriaas - immunosupressandid - kyntheum on näidustatud mõõduka kuni raske naastulise psoriaasi raviks täiskasvanud patsientidel, kes saavad süsteemset ravi.
skilarence
almirall s.a - dimetüülfumaraat - psoriaas - immunosupressandid - sidumisvastased ravimid on näidustatud mõõduka kuni raskekujulise naastulise psoriaasi ravis täiskasvanutel, kes vajavad süsteemset meditsiinilist ravi.
tremfya
janssen-cilag international nv - guselkumab - psoriaas - immunosupressandid - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.
ilumetri
almirall s.a - tildrakizumab - psoriaas - immunosuppressants, interleukiin inhibiitorid, - ilumetri on näidustatud ravi täiskasvanute mõõduka kuni raske psoriaas, kes kandideerivad süsteemne ravi.
cezera 5 mg õhukese polümeerikattega tablett
krka d.d. novo mesto - levotsetirisiin - õhukese polümeerikattega tablett - 5mg 28tk; 5mg 20tk; 5mg 7tk; 5mg 100tk; 5mg 10tk; 5mg 98tk; 5mg 50tk; 5mg 30tk; 5mg 14tk
bimzelx
ucb pharma s.a. - bimekizumab - psoriaas - immunosupressandid - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.
alpivab
biocryst - peramivir - gripp, inimene - viirusevastased ravimid süsteemseks kasutamiseks - alpivab on näidustatud ravi lihtne gripi täiskasvanutele ja lastele alates vanusest 2 aastat.